Our structured lipid platform allows for improved absorption of healthy fat calories, essential fatty acids, and nutrients.

Our first product, Encala® is clinically proven to improve weight, height, and body mass in patients with fat malabsorption.

Encala was developed to help the 1.5 billion people who have a digestive disease and others who have unintentional weight loss or difficulty gaining weight due to malabsorption.

We can use our technology platform to enter additional product categories, and are pursuing a suite of infant nutrition products and liquid formulations, including a tube feed formula.

Power Your Potential